- 1,067
Express Scripts is joining CVS Health in moving away from offering Humira as a standard prescription drug option for people with arthritis, Crohn's disease and other autoimmune disorders.
The pharmacy benefit manager said last week that it will shift to offering competitors to the popular drug through its main formularies, or covered drug lists.
Humira is a brand name for adalimumab, an injectable natural substance, or "biologic medication," that can help patients cope with conditions that cause a patient's immune system to attack the patient's own body.
AbbVie, the manufacturer, has been selling the drug with a suggested retail price of about $7,000. The drug's patent expired in early 2023. Since then, many manufacturers have rushed to develop biosimilars.
Humira was the most expensive drug for U.S. employers in 2023, and it accounted for an average of $145 of plan spending per plan enrollee, according to Milliman.
https://www.benefitspro.com/2024/08...5fb5dbdc728b23d759e55fc18460862605a7487083e0a
The pharmacy benefit manager said last week that it will shift to offering competitors to the popular drug through its main formularies, or covered drug lists.
Humira is a brand name for adalimumab, an injectable natural substance, or "biologic medication," that can help patients cope with conditions that cause a patient's immune system to attack the patient's own body.
AbbVie, the manufacturer, has been selling the drug with a suggested retail price of about $7,000. The drug's patent expired in early 2023. Since then, many manufacturers have rushed to develop biosimilars.
Humira was the most expensive drug for U.S. employers in 2023, and it accounted for an average of $145 of plan spending per plan enrollee, according to Milliman.
https://www.benefitspro.com/2024/08...5fb5dbdc728b23d759e55fc18460862605a7487083e0a
